BeOne Medicines (ONC) Capital Expenditures Growth (1y) (2016 - 2026)
BeOne Medicines (ONC) Capital Expenditures Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 143.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.93% |
| Dec 31, 2025 | -1,719.59% |
| Sep 30, 2025 | 219.47% |
| Jun 30, 2025 | 198.07% |
| Mar 31, 2025 | -61.67% |
| Dec 31, 2024 | 68.35% |
| Sep 30, 2024 | 71.14% |
| Jun 30, 2024 | -122.41% |
| Mar 31, 2024 | 144.60% |
| Dec 31, 2023 | -113.03% |
| Sep 30, 2023 | -195.90% |
| Jun 30, 2023 | 1,251.36% |
| Mar 31, 2023 | 41.84% |
| Dec 31, 2022 | 973.96% |
| Sep 30, 2022 | 472.60% |
| Jun 30, 2022 | -72.92% |
| Mar 31, 2022 | 46.03% |
| Dec 31, 2021 | -67.42% |
| Sep 30, 2021 | -236.06% |
| Jun 30, 2021 | 80.39% |